Current and historical daily PE Ratio for Almirall SA (
) from 2022 to Jun 19 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Almirall stock (WBO:ALM) PE ratio as of Jun 19 2024 is 187.48.
More Details
Almirall SA (WBO:ALM) PE Ratio (TTM) Chart
Almirall SA (WBO:ALM) PE Ratio (TTM) Historical Data
View and export this data going back to 2022. Start your Free Trial
Total 381
- 1
- 2
- 3
- 4
- 5
Almirall PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-19 | 177.5 | 2024-04-16 | 145.7 |
2024-06-18 | 177.5 | 2024-04-15 | 146.1 |
2024-06-17 | 175.4 | 2024-04-12 | 146.8 |
2024-06-14 | 166.6 | 2024-04-11 | 145.9 |
2024-06-13 | 166.6 | 2024-04-10 | 145.9 |
2024-06-12 | 166.6 | 2024-04-09 | 146.9 |
2024-06-11 | 166.6 | 2024-04-08 | 145.3 |
2024-06-10 | 166.6 | 2024-04-05 | 146.1 |
2024-06-07 | 166.6 | 2024-04-04 | 147.1 |
2024-06-06 | 172.1 | 2024-04-03 | 145.0 |
2024-06-05 | 172.9 | 2024-04-02 | 147.6 |
2024-06-04 | 174.5 | 2024-03-29 | 146.7 |
2024-06-03 | 174.5 | 2024-03-28 | 146.7 |
2024-05-31 | 173.9 | 2024-03-27 | 130.4 |
2024-05-30 | 173.8 | 2024-03-26 | 127.8 |
2024-05-29 | 175.4 | 2024-03-25 | 127.2 |
2024-05-28 | 174.1 | 2024-03-22 | 128.0 |
2024-05-27 | 172.4 | 2024-03-21 | 126.1 |
2024-05-24 | 171.4 | 2024-03-20 | 126.4 |
2024-05-23 | 170.9 | 2024-03-19 | 125.7 |
2024-05-22 | 169.9 | 2024-03-18 | 127.2 |
2024-05-21 | 168.4 | 2024-03-15 | 127.7 |
2024-05-20 | 166.3 | 2024-03-14 | 129.6 |
2024-05-17 | 168.4 | 2024-03-13 | 130.4 |
2024-05-16 | 170.4 | 2024-03-12 | 130.7 |
2024-05-15 | 170.4 | 2024-03-11 | 129.8 |
2024-05-14 | 170.4 | 2024-03-08 | 128.8 |
2024-05-13 | 170.4 | 2024-03-07 | 127.8 |
2024-05-10 | 162.8 | 2024-03-06 | 127.9 |
2024-05-09 | 159.9 | 2024-03-05 | 126.9 |
2024-05-08 | 158.3 | 2024-03-04 | 128.3 |
2024-05-07 | 154.1 | 2024-03-01 | 127.2 |
2024-05-06 | 155.4 | 2024-02-29 | 129.2 |
2024-05-03 | 154.3 | 2024-02-28 | 131.2 |
2024-05-02 | 153.3 | 2024-02-27 | 132.1 |
2024-04-30 | 151.1 | 2024-02-26 | 131.9 |
2024-04-29 | 152.7 | 2024-02-23 | 144.3 |
2024-04-26 | 151.3 | 2024-02-22 | 144.3 |
2024-04-25 | 149.4 | 2024-02-21 | 144.3 |
2024-04-24 | 149.6 | 2024-02-20 | 144.3 |
2024-04-23 | 147.7 | 2024-02-19 | 136.0 |
2024-04-22 | 148.0 | 2024-02-16 | 136.8 |
2024-04-19 | 146.7 | 2024-02-15 | 135.3 |
2024-04-18 | 145.1 | 2024-02-14 | 134.3 |
2024-04-17 | 144.6 | 2024-02-13 | 135.4 |
Almirall SA (WBO:ALM) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Almirall SA
ISIN : ES0157097017
Compare
Compare
Traded in other countries / regions
ALM.Spain0O9B.UKE2Z.GermanyALM.AustriaLBTSF.USA IPO Date
2022-12-21Description
Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.